National Patient Safety Alert · NatPSA/2023/004/MHRA
National Patient Safety Alert: Class 1 Medicines Recall: Emerade 500 micrograms and Emerade 300 micrograms auto-injectors
NatPSA/2023/004/MHRA issued 09 May 2023
What changed
- 09 May 2023National Patient Safety Alert issuedsource post
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
post:8b24d70762e8
- Recorded
- 11 Jun 2023 03:48 UTC (Internet Archive capture)the earliest capture we hold is the Internet Archive's, not first-hand
- Capture route
- Recovered from the Internet Archive — not first-hand capture
- Read from
- Community Pharmacy England post (DHSC notification as relayed)
- Captured at
- 11 Jun 2023 03:48 UTC
- Content hash
acab9293f3591f9d6efe8305f7134e46a0dea30d6fa6dbfd0ef4098e1dc9a48csha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://cpe.org.uk/our-news/national-patient-safety-alert-class-1-medicines-recall-emerade-500-micrograms-and-emerade-300-micrograms-auto-injectors ↗
- Archive capture
- https://web.archive.org/web/20230611034822id_/https://cpe.org.uk/our-news/national-patient-safety-alert-class-1-medicines-recall-emerade-500-micrograms-and-emerade-300-micrograms-auto-injectors ↗
- Parser version
- 3
Dates are as stated in the source documents. Fuzzy source dates are kept fuzzy. Not an official NHS or DHSC service — in a shortage, follow the guidance issued to your pharmacy or prescriber.